Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19.
Eto S, Nukui Y, Tsumura M, Nakagama Y, Kashimada K, Mizoguchi Y, Utsumi T, Taniguchi M, Sakura F, Noma K, Yoshida Y, Ohshimo S, Nagashima S, Okamoto K, Endo A, Imai K, Kanegane H, Ohnishi H, Hirata S, Sugiyama E, Shime N, Ito M, Ohge H, Kido Y, Bastard P, Casanova JL, Ohara O, Tanaka J, Morio T, Okada S.
Eto S, et al. Among authors: okada s.
J Clin Immunol. 2022 Oct;42(7):1360-1370. doi: 10.1007/s10875-022-01308-3. Epub 2022 Jun 29.
J Clin Immunol. 2022.
PMID: 35764767
Free PMC article.